PTTG1 overexpression in adrenocortical cancer is associated with poor survival and represents a potential therapeutic target.
PTTG1 overexpression in adrenocortical cancer is associated with poor survival and represents a potential therapeutic target. Surgery. 2013 Dec; 154(6):1405-16; discussion 1416.